Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Myo5c | Rat | (+)-catechin | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | [Catechin co-treated with Grape Seed Proanthocyanidins] results in increased expression of MYO5C mRNA | CTD | PMID:24763279 | Myo5c | Rat | 1,2-dichloroethane | decreases expression | ISO | Myo5c (Mus musculus) | 6480464 | ethylene dichloride results in decreased expression of MYO5C mRNA | CTD | PMID:28960355 | Myo5c | Rat | 1,2-dimethylhydrazine | decreases expression | ISO | Myo5c (Mus musculus) | 6480464 | 1,2-Dimethylhydrazine results in decreased expression of MYO5C mRNA | CTD | PMID:22206623 | Myo5c | Rat | 17beta-estradiol | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | [Estradiol co-treated with TGFB1 protein] results in decreased expression of MYO5C mRNA | CTD | PMID:30165855 | Myo5c | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MYO5C mRNA | CTD | PMID:21632981 | Myo5c | Rat | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | ISO | Myo5c (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of MYO5C mRNA | CTD | PMID:33956508 | Myo5c | Rat | 3-Nitrobenzanthrone | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | 3-nitrobenzanthrone results in decreased expression of MYO5C mRNA | CTD | PMID:34036453 | Myo5c | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Myo5c (Mus musculus) | 6480464 | bisphenol S results in increased expression of MYO5C mRNA | CTD | PMID:30951980 | Myo5c | Rat | 4,4'-sulfonyldiphenol | affects methylation | ISO | Myo5c (Mus musculus) | 6480464 | bisphenol S affects the methylation of MYO5C gene | CTD | PMID:31683443 | Myo5c | Rat | 6-propyl-2-thiouracil | increases expression | EXP | | 6480464 | Propylthiouracil results in increased expression of MYO5C mRNA | CTD | PMID:30047161 | Myo5c | Rat | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of MYO5C mRNA | CTD | PMID:28959563 | Myo5c | Rat | aflatoxin B1 | increases methylation | ISO | MYO5C (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased methylation of MYO5C exon | CTD | PMID:30157460 | Myo5c | Rat | all-trans-retinoic acid | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | Tretinoin results in decreased expression of MYO5C mRNA | CTD | PMID:23724009 | Myo5c | Rat | amitrole | increases expression | EXP | | 6480464 | Amitrole results in increased expression of MYO5C mRNA | CTD | PMID:30047161 | Myo5c | Rat | antirheumatic drug | increases expression | ISO | MYO5C (Homo sapiens) | 6480464 | Antirheumatic Agents results in increased expression of MYO5C mRNA | CTD | PMID:24449571 | Myo5c | Rat | arsane | affects methylation | ISO | MYO5C (Homo sapiens) | 6480464 | Arsenic affects the methylation of MYO5C gene | CTD | PMID:25304211 | Myo5c | Rat | arsane | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Myo5c | Rat | arsenic atom | affects methylation | ISO | MYO5C (Homo sapiens) | 6480464 | Arsenic affects the methylation of MYO5C gene | CTD | PMID:25304211 | Myo5c | Rat | arsenic atom | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Myo5c | Rat | arsenite(3-) | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | arsenite inhibits the reaction [G3BP1 protein binds to MYO5C mRNA] | CTD | PMID:32406909 | Myo5c | Rat | arsenous acid | decreases response to substance | ISO | MYO5C (Homo sapiens) | 6480464 | MYO5C protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 | Myo5c | Rat | atrazine | affects methylation | EXP | | 6480464 | Atrazine affects the methylation of MYO5C gene | CTD | PMID:35440735 | Myo5c | Rat | azathioprine | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | Azathioprine results in decreased expression of MYO5C mRNA | CTD | PMID:22623647 | Myo5c | Rat | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of MYO5C mRNA | CTD | PMID:21839799 | Myo5c | Rat | benzo[a]pyrene | affects methylation | ISO | MYO5C (Homo sapiens) | 6480464 | Benzo(a)pyrene affects the methylation of MYO5C exon; Benzo(a)pyrene affects the methylation of MYO5C promoter | CTD | PMID:27901495|PMID:30157460 | Myo5c | Rat | benzo[a]pyrene | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of MYO5C mRNA | CTD | PMID:20106945|PMID:21632981|PMID:26238291 | Myo5c | Rat | benzo[e]pyrene | increases methylation | ISO | MYO5C (Homo sapiens) | 6480464 | benzo(e)pyrene results in increased methylation of MYO5C exon | CTD | PMID:30157460 | Myo5c | Rat | bis(2-ethylhexyl) phthalate | decreases expression | ISO | Myo5c (Mus musculus) | 6480464 | Diethylhexyl Phthalate results in decreased expression of MYO5C mRNA | CTD | PMID:34319233 | Myo5c | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of MYO5C mRNA | CTD | PMID:25181051 | Myo5c | Rat | bisphenol A | decreases expression | ISO | Myo5c (Mus musculus) | 6480464 | bisphenol A results in decreased expression of MYO5C mRNA | CTD | PMID:32156529 | Myo5c | Rat | bisphenol A | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | [Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of MYO5C protein | CTD | PMID:31629898 | Myo5c | Rat | bisphenol A | increases expression | ISO | Myo5c (Mus musculus) | 6480464 | bisphenol A results in increased expression of MYO5C mRNA | CTD | PMID:25594700 | Myo5c | Rat | bisphenol F | increases expression | ISO | Myo5c (Mus musculus) | 6480464 | bisphenol F results in increased expression of MYO5C mRNA | CTD | PMID:30951980 | Myo5c | Rat | bisphenol F | decreases expression | ISO | Myo5c (Mus musculus) | 6480464 | bisphenol F results in decreased expression of MYO5C mRNA | CTD | PMID:38685157 | Myo5c | Rat | butanal | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | butyraldehyde results in decreased expression of MYO5C mRNA | CTD | PMID:26079696 | Myo5c | Rat | cadmium atom | multiple interactions | ISO | Myo5c (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MYO5C more ... | CTD | PMID:28111341 | Myo5c | Rat | cadmium dichloride | multiple interactions | ISO | Myo5c (Mus musculus) | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of MYO5C more ... | CTD | PMID:28111341 | Myo5c | Rat | carbon nanotube | decreases expression | ISO | Myo5c (Mus musculus) | 6480464 | Nanotubes, Carbon analog results in decreased expression of MYO5C mRNA | CTD | PMID:25554681 | Myo5c | Rat | CGP 52608 | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to MYO5C gene] | CTD | PMID:28238834 | Myo5c | Rat | cisplatin | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | Cisplatin results in decreased expression of MYO5C mRNA | CTD | PMID:27392435 | Myo5c | Rat | cobalt dichloride | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of MYO5C mRNA | CTD | PMID:19376846 | Myo5c | Rat | copper(II) sulfate | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | Copper Sulfate results in decreased expression of MYO5C mRNA | CTD | PMID:19549813 | Myo5c | Rat | CU-O LINKAGE | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | cupric oxide results in decreased expression of MYO5C mRNA | CTD | PMID:22077320 | Myo5c | Rat | Cuprizon | increases expression | EXP | | 6480464 | Cuprizone results in increased expression of MYO5C mRNA | CTD | PMID:26577399 | Myo5c | Rat | cyclosporin A | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of MYO5C mRNA | CTD | PMID:25562108 | Myo5c | Rat | deoxynivalenol | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | deoxynivalenol results in decreased expression of MYO5C mRNA | CTD | PMID:26763390 | Myo5c | Rat | diarsenic trioxide | decreases response to substance | ISO | MYO5C (Homo sapiens) | 6480464 | MYO5C protein results in decreased susceptibility to Arsenic Trioxide | CTD | PMID:20707922 | Myo5c | Rat | dinophysistoxin 1 | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | dinophysistoxin 1 results in decreased expression of MYO5C mRNA | CTD | PMID:28939011 | Myo5c | Rat | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of MYO5C mRNA | CTD | PMID:21551480 | Myo5c | Rat | dorsomorphin | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Myo5c | Rat | glyphosate | increases methylation | EXP | | 6480464 | Glyphosate results in increased methylation of MYO5C gene | CTD | PMID:31011160 | Myo5c | Rat | glyphosate | decreases expression | EXP | | 6480464 | Glyphosate results in decreased expression of MYO5C mRNA | CTD | PMID:38314887 | Myo5c | Rat | manganese atom | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Myo5c | Rat | manganese(0) | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Myo5c | Rat | manganese(II) chloride | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Myo5c | Rat | methapyrilene | increases methylation | ISO | MYO5C (Homo sapiens) | 6480464 | Methapyrilene results in increased methylation of MYO5C exon | CTD | PMID:30157460 | Myo5c | Rat | methimazole | increases expression | EXP | | 6480464 | Methimazole results in increased expression of MYO5C mRNA | CTD | PMID:30047161 | Myo5c | Rat | N-nitrosodiethylamine | increases expression | ISO | Myo5c (Mus musculus) | 6480464 | Diethylnitrosamine results in increased expression of MYO5C mRNA | CTD | PMID:24535843 | Myo5c | Rat | nickel atom | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | Nickel results in decreased expression of MYO5C mRNA | CTD | PMID:24768652|PMID:25583101 | Myo5c | Rat | nickel sulfate | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | nickel sulfate results in decreased expression of MYO5C mRNA | CTD | PMID:22714537 | Myo5c | Rat | nitrofen | increases expression | EXP | | 6480464 | nitrofen results in increased expression of MYO5C mRNA | CTD | PMID:33484710 | Myo5c | Rat | oxaliplatin | decreases expression | EXP | | 6480464 | oxaliplatin results in decreased expression of MYO5C mRNA | CTD | PMID:25729387 | Myo5c | Rat | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of MYO5C mRNA | CTD | PMID:25729387 | Myo5c | Rat | paracetamol | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | Acetaminophen results in decreased expression of MYO5C mRNA | CTD | PMID:21420995 | Myo5c | Rat | perfluorohexanesulfonic acid | decreases expression | ISO | Myo5c (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in decreased expression of MYO5C mRNA | CTD | PMID:37995155 | Myo5c | Rat | phenol red | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | [Phenolsulfonphthalein deficiency co-treated with bisphenol A] results in increased expression of MYO5C protein | CTD | PMID:31629898 | Myo5c | Rat | phenylmercury acetate | increases expression | ISO | MYO5C (Homo sapiens) | 6480464 | Phenylmercuric Acetate results in increased expression of MYO5C mRNA | CTD | PMID:26272509 | Myo5c | Rat | phenylmercury acetate | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Myo5c | Rat | propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of MYO5C mRNA | CTD | PMID:30047161 | Myo5c | Rat | quercetin | decreases expression | EXP | | 6480464 | Quercetin results in decreased expression of MYO5C mRNA | CTD | PMID:18095365 | Myo5c | Rat | SB 431542 | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Myo5c | Rat | silicon dioxide | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | Silicon Dioxide results in decreased expression of MYO5C mRNA | CTD | PMID:25351596 | Myo5c | Rat | sodium arsenite | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | sodium arsenite results in decreased expression of MYO5C mRNA | CTD | PMID:38568856 | Myo5c | Rat | sodium arsenite | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | [[sodium arsenite results in increased abundance of Arsenic] co-treated with [manganese chloride results in increased more ... | CTD | PMID:39836092 | Myo5c | Rat | sotorasib | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MYO5C mRNA | CTD | PMID:36139627 | Myo5c | Rat | sulfadimethoxine | increases expression | EXP | | 6480464 | Sulfadimethoxine results in increased expression of MYO5C mRNA | CTD | PMID:30047161 | Myo5c | Rat | tert-butyl hydroperoxide | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | tert-Butylhydroperoxide results in decreased expression of MYO5C mRNA | CTD | PMID:15336504 | Myo5c | Rat | thiram | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | Thiram results in decreased expression of MYO5C mRNA | CTD | PMID:38568856 | Myo5c | Rat | titanium dioxide | decreases methylation | ISO | Myo5c (Mus musculus) | 6480464 | titanium dioxide results in decreased methylation of MYO5C promoter | CTD | PMID:35295148 | Myo5c | Rat | topotecan | decreases expression | EXP | | 6480464 | Topotecan results in decreased expression of MYO5C mRNA | CTD | PMID:25729387 | Myo5c | Rat | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of MYO5C mRNA | CTD | PMID:25729387 | Myo5c | Rat | trametinib | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in increased expression of MYO5C mRNA | CTD | PMID:36139627 | Myo5c | Rat | tributylstannane | increases expression | ISO | Myo5c (Mus musculus) | 6480464 | tributyltin results in increased expression of MYO5C mRNA | CTD | PMID:31939706 | Myo5c | Rat | trichostatin A | increases expression | ISO | MYO5C (Homo sapiens) | 6480464 | trichostatin A results in increased expression of MYO5C mRNA | CTD | PMID:24935251 | Myo5c | Rat | triphenyl phosphate | affects expression | ISO | MYO5C (Homo sapiens) | 6480464 | triphenyl phosphate affects the expression of MYO5C mRNA | CTD | PMID:37042841 | Myo5c | Rat | Triptolide | increases expression | EXP | | 6480464 | triptolide results in increased expression of MYO5C protein | CTD | PMID:32519852 | Myo5c | Rat | tunicamycin | increases expression | ISO | MYO5C (Homo sapiens) | 6480464 | Tunicamycin results in increased expression of MYO5C mRNA | CTD | PMID:29453283 | Myo5c | Rat | urethane | decreases expression | ISO | MYO5C (Homo sapiens) | 6480464 | Urethane results in decreased expression of MYO5C mRNA | CTD | PMID:28818685 | Myo5c | Rat | valproic acid | increases expression | ISO | Myo5c (Mus musculus) | 6480464 | Valproic Acid results in increased expression of MYO5C mRNA | CTD | PMID:21427059 | Myo5c | Rat | valproic acid | increases expression | ISO | MYO5C (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of MYO5C mRNA | CTD | PMID:23179753|PMID:24935251|PMID:26272509|PMID:27188386 | Myo5c | Rat | valproic acid | multiple interactions | ISO | MYO5C (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased more ... | CTD | PMID:27188386 | Myo5c | Rat | valproic acid | affects expression | ISO | MYO5C (Homo sapiens) | 6480464 | Valproic Acid affects the expression of MYO5C mRNA | CTD | PMID:25979313 | Myo5c | Rat | vinclozolin | affects expression | EXP | | 6480464 | vinclozolin affects the expression of MYO5C mRNA | CTD | PMID:19015723 | Myo5c | Rat | vinclozolin | increases methylation | EXP | | 6480464 | vinclozolin results in increased methylation of MYO5C gene | CTD | PMID:31079544 | | |||||||||||||||||||||||||||||||||||||||||||||||||






















